Clinical Trial Update: Reduced-intensity Immunoablation and Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Multiple Sclerosis [Phase 1]

View source ↗

Summary

Phase 1 trial update on reduced-intensity immunoablation followed by autologous hematopoietic stem cell transplantation for multiple sclerosis. The current stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Makati Medical Center | Conditions: Multiple Sclerosis | Phase 1 | Status: UNKNOWN